Company / Revenue
Chemed Corp. Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$2.5B
FY2025
5-year range
$2.1B / $2.5B
FY2021-FY2025
Trend
+4.1%
vs FY2024
Sector context
#71 of 150
Health Care
What the data says
At $2.5B, Chemed Corp.'s revenue ranks #71 of 150 in the Health Care sector. Revenue has increased for 3 consecutive years, from $2.1B in FY2022 to $2.5B in FY2025.
Based on SEC 10-K filings.
$2.5B in FY2025 with a 5-year CAGR of +4.0%.
Improved from $2.3B to $2.5B over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +5.8%
- 5-Year CAGR
- +4.0%
- 10-Year CAGR
- -
Sector benchmark
#71 of 150 in Health CareTop 47% of 150This company $2.5B Sector average $19.5B
▼
-87.0% below sector average
Key checks
Key Insights
- Chemed Corp.'s revenue has grown for 3 consecutive years.
- 5-year CAGR of +4.0%, indicating consistent growth.
- In FY2025, revenue increased 4.1% year-over-year.
- Ranks #71 out of 150 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 4.70 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.5B | +4.1% |
| FY2024 | $2.4B | +7.4% |
| FY2023 | $2.3B | +6.1% |
| FY2022 | $2.1B | -0.2% |
| FY2021 | $2.1B | +2.9% |
| FY2020 | $2.1B | +7.3% |
| FY2019 | $1.9B | +8.7% |
| FY2018 | $1.8B | +7.0% |
| FY2017 | $1.7B | +5.7% |
| FY2016 | $1.6B | +2.2% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026